Risks, regulation, and rewards in new drug development in the United States

Regul Toxicol Pharmacol. 1994 Apr;19(2):228-35. doi: 10.1006/rtph.1994.1021.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Chemistry, Pharmaceutical / economics*
  • Chemistry, Pharmaceutical / legislation & jurisprudence*
  • Drug Approval
  • Health Care Reform
  • Legislation, Drug
  • Marketing of Health Services
  • Risk Factors
  • United States